(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American…
MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer's disease and type 2 diabetes…
Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine…